By Bill Berkrot NEW YORK (Reuters) – Little known biotechnology company Merrimack Pharmaceuticals Inc has quietly built a large pipeline of experimental cancer treatments that it aims to deliver at a fraction of the cost spent by larger rivals. That could translate into lower-cost treatments for large unmet needs, such as pancreatic cancer, at precisely the time when pressure is mounting to reduce runaway healthcare spending. Despite six drugs in clinical development – one of
(More)…
Debra Belancik, safety representative of the International Association of Machinists, which represents Pratt Whitney workers, said she hopes the report ends the matter with conclusive information. Article source: http://www.boston.com/news/local/connecticut/2013/05/23/decade-long-cancer-study-pratt-whitney-ends/54yN6HKNRrLiETnUYJjwKN/story.html
Wed May 22, 2013 9:46am EDT (Reuters) – Oncolytics Biotech Inc said preliminary data from a mid-stage trial showed that its cancer drug, Reolysin, met the main goal of reducing the size of tumors in patients with metastatic melanoma, a type of skin cancer. Shares of the Calgary-based company rose as much as 11 percent to C$3.14 on the Toronto Stock Exchange on Wednesday. Its Nasdaq-listed shares were up 10 percent. Reolysin was administered intravenously
(More)…
Recently, Angelina Jolie revealed that she “decided to be proactive” and underwent a preventive double mastectomy upon discovering she had the gene that would most likely cause her to develop breast cancer. I enjoy her movies and admire her work with the U.N., but I truly respect her for being such an incredible role model for women who are faced with similar odds. Arguably one of the most beautiful women in the world, Angelina is
(More)…
CT Scans Reduce Lung Cancer Deaths, Study Confirms By Randy Dotinga HealthDay Reporter WEDNESDAY, May 22 (HealthDay News) — Physicians weighing the benefits and risks of CT scans for detecting lung cancer now have more information to help with the decision. A new analysis of a 2010 U.S. study finds that low-dose CT scans pick up significantly more lung tumors than chest X-rays do. People with a long history of smoking are at high risk
(More)…
BioMarin Pharmaceutical Inc. (BMRN), a maker of drugs for rare diseases, rose the most in more than six months ahead of a medical conference where the company plans to publish data on its experimental cancer therapy. BioMarin gained 2.5 percent to $66.59 at 2:05 p.m. in New York, after jumping 7.4 percent earlier, its largest intraday increase since Nov. 15. The Novato, California-based company had increased 32 percent this year through yesterday. BioMarin said it
(More)…
WEDNESDAY, May 22 (HealthDay News) — The American Cancer Society, which is celebrating on Wednesday a century of fighting a disease once viewed as a death sentence, is making a pledge to put itself out of business. Since 1913, the cancer society has played a role in nearly every major cancer research breakthrough. This year alone, the group reported a 20 percent drop in cancer death rates since the 1990s, which amounts to more than
(More)…
A team of researchers at UC Irvine are developing a what it hopes will be a more reliable prostate cancer test that uses urine instead of blood. It involves urinating on a stick coated with a virus that attracts a protein associated with the disease. It would also be very inexpensive. Every year roughly 240,000 men in the US are diagnosed with prostate cancer. The current testing method often finds tumors that are low risk and
(More)…
Medicare Has Stopped Paying Bills For Medical Diagnostic Tests. Patients Will Feel The Effects Scott Gottlieb Contributor Unhealthy Prognosis for Venture-Backed Diagnostics Bruce Booth Contributor By Scott Gottlieb, MD Medicare has sharply changed the way it pays for diagnostic tests, cutting payment rates and curtailing coverage for some new tests altogether. The makeover in the way that Medicare reimburses molecular diagnostics has been foreshadowed for years, but was abruptly put into effect this summer. Affected
(More)…
Celebs 4 hours ago Dame Helen Mirren all by herself is pretty terrific. But put the 70-year-old Oscar winner in the outfit of the Queen, and she wears it like a superhero. Recently, she stormed outside mid-performance of her London show “The Audience” (in which she plays Queen Elizabeth II) to unload on noisy drummers (and later publicly wore a handmade T-shirt supporting their cause). But her latest deed goes one step further: Last week,
(More)…